MCL1 and amyotrophic lateral sclerosis: MCL-1 knockdown in HCT116+/+ cells partially abrogated the protective effects of QARS overexpression or glutamine supplementation against HU- (Fig. 5K and 5L) or ALS-induced apoptosis (Fig. S4G and S4H).